Cargando…

A systematic review of transition studies of pulmonary arterial hypertension specific medications

Pulmonary arterial hypertension (PAH) is a progressive potentially fatal disease. Multiple pharmacologic options are now available, which facilitated transitions between different therapeutic options, although the evidence for such transitions has not been well described. We sought to review the evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sofer, Avraham, Ryan, Michael J., Tedford, Ryan J., Wirth, Joel A., Fares, Wassim H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467943/ https://www.ncbi.nlm.nih.gov/pubmed/28597769 http://dx.doi.org/10.1177/2045893217706357

Ejemplares similares

Single‐Beat Estimation of Right Ventricular Contractility and Its Coupling to Pulmonary Arterial Load in Patients With Pulmonary Hypertension
por: Inuzuka, Ryo, et al.
Publicado: (2018)

Are you Coupled? Hemodynamic Phenotyping in Pulmonary Hypertension
por: Friedman, Samuel H, et al.
Publicado: (2022)

Macitentan for the treatment of pulmonary arterial hypertension
por: Kholdani, Cyrus A, et al.
Publicado: (2014)

Safety and feasibility of obtaining wedged pulmonary artery samples and differential distribution of biomarkers in pulmonary hypertension
por: Fares, Wassim H., et al.
Publicado: (2012)

Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
por: Pan, Irene Z., et al.
Publicado: (2020)

Is hyponatremia associated with mortality in pulmonary arterial hypertension?
por: Rudkovskaia, Anastasiia A., et al.
Publicado: (2018)

Pulmonary hypertension: diagnostic and therapeutic challenges
por: Bazan, Isabel S, et al.
Publicado: (2015)

Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
por: Hsu, Steven, et al.
Publicado: (2020)

Lupus-Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition
por: Mensah, Kofi A., et al.
Publicado: (2015)

Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Clapham, Katharine R., et al.
Publicado: (2020)

Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis
por: Pitre, Tyler, et al.
Publicado: (2022)

Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
por: Mercurio, Valentina, et al.
Publicado: (2018)

Pulmonary hypertension due to left heart disease
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension
por: Hsu, Steven, et al.
Publicado: (2017)

Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans
por: Blanco, Isabel, et al.
Publicado: (2014)

Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension
por: Marshall, Jeffrey D., et al.
Publicado: (2017)

Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?
por: Tonelli, Adriano R., et al.
Publicado: (2017)

Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

Management of Pulmonary Arterial Hypertension
por: Mayeux, Jennalyn D., et al.
Publicado: (2020)

Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Treatment of pulmonary hypertension in three patients with β-thalassemia intermedia using pulmonary arterial hypertension-specific medications
por: Gerede, Demet Menekşe, et al.
Publicado: (2016)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Putting “At‐Rest” Evaluations of the Right Ventricle to Rest: Insights Gained From Evaluation of the Right Ventricle During Exercise in CTEPH Patients With and Without Pulmonary Endarterectomy
por: Houston, Brian A., et al.
Publicado: (2015)

Chronic Thromboembolic Pulmonary Hypertension Medical Management
por: Logue, Ryan, et al.
Publicado: (2021)

A composite sleep and pulmonary phenotype predicting hypertension
por: Li, Ruitong, et al.
Publicado: (2021)

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
por: Safdar, Zeenat
Publicado: (2011)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy
por: Ataya, Ali, et al.
Publicado: (2016)

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
por: Alfraidi, Hassan, et al.
Publicado: (2018)

Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
por: Alamri, Ayedh K., et al.
Publicado: (2023)

Metallomics in pulmonary arterial hypertension patients
por: El‐Kersh, Karim, et al.
Publicado: (2023)

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
por: Bourji, Khalil I., et al.
Publicado: (2017)

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
por: Ivy, D. Dunbar, et al.
Publicado: (2019)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis
por: Ryerson, Christopher J, et al.
Publicado: (2010)

A systematic review of genetic mutations in pulmonary arterial hypertension
por: Garcia-Rivas, Gerardo, et al.
Publicado: (2017)

Schistosomiasis-associated pulmonary arterial hypertension: a systematic review
por: Knafl, Daniela, et al.
Publicado: (2020)

Risk stratification and medical therapy of pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension
por: Idrees, Majdy M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bd4892s5e573bapld26m5ale5q